Showing results (31-40 of 63) with videos related to
Sort By:
Pageof 7
American Health & Drug Benefits|August 16, 2014
The economic burden of ischemic stroke and major hemorrhage in medicare beneficiaries with nonvalvular atrial fibrillation: a retrospective claims analysisKathryn Fitch, Jonah Broulette, Winghan Jacqueline KwongCurrent Medical Research and Opinion|March 23, 2017
Cost comparison of laparoscopic colectomy versus open colectomy in colon cancerKathryn Fitch, Andrew Bochner, Deborah S KellerAmerican Health & Drug Benefits|August 11, 2017
The Clinical and Economic Burden of Hyperkalemia on Medicare and Commercial PayersKathryn Fitch, J Michael Woolley, Tyler Engel, et al.Journal of Managed Care & Specialty Pharmacy|October 22, 2021
Greater uptake, an alternative reimbursement methodology needed to realize cost-saving potential of oncology biosimilars in the United StatesJingyan Yang, Jennifer Carioto, Bruce Pyenson, et al.American Health & Drug Benefits|July 27, 2019
Prevalence and Economic Burden of Epilepsy in the Institutionalized Medicare Fee-for-Service PopulationKathryn Fitch, Xiaoyun Pan, Jocelyn Lau, et al.Journal of Managed Care & Specialty Pharmacy|June 25, 2019
The Real-World Medicare Costs of Alzheimer Disease: Considerations for Policy and CareBruce Pyenson, Tia Goss Sawhney, Charles Steffens, et al.Current Medical Research and Opinion|June 23, 2017
Cardiovascular event incidence and cost in type 2 diabetes mellitus: a Medicare claims-based actuarial analysisKathryn Fitch, Tyler Engel, Stephen Sander, et al.American Health & Drug Benefits|July 4, 2014
National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costsBetsy J Lahue, Bruce Pyenson, Kosuke Iwasaki, et al.Journal of Health Economics and Outcomes Research|February 6, 2023
PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD PopulationGerard Criner, Fernando Martinez, Hitesh Gandhi, et al.Borderline Personality Disorder and Emotion Dysregulation|September 25, 2015
Stigma towards borderline personality disorder: effectiveness and generalizability of an anti-stigma program for healthcare providers using a pre-post randomized designStephanie Knaak, Andrew Ch Szeto, Kathryn Fitch, et al.Pageof 7